Impact of SARS-CoV-2 Vaccination on Treatment for Patients With Breast Cancer
Breast Cancer Research and Treatment (Breast Cancer Res Treat. 2022 Oct;195(3):311-323. doi: 10.1007/s10549-022-06693-2. Epub 2022 Aug 8)
TAKE-HOME MESSAGE
"This prospective observational study evaluated the efficacy and impact of vaccination against SARS-CoV-2 variants on therapy among patients with breast cancer. Compared with patients not treated with systemic treatment, antibody concentration significantly decreased after COVID-19 vaccination in patients treated with chemotherapy or CDK4/6 inhibitors, despite a high seroconversion rate.
Seroconversion demonstrates poor concordance with neutralizing antibody titers against SARS-CoV-2 variants among patients with cancer. For patients receiving chemotherapy or CDK4/6 inhibitors, infection-prevention measures and COVID-19 booster vaccination are strongly recommended."